AnodyneWiki

Capsaicin

Capsaicin
Capsaicin
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass305.40 g/mol [1]
AppearancePure dark red solid [1]
OdorHighly volatile with a pungent odor [1]
TasteBurning taste detectable in 1 part in 100,000 [1]
Melting point65 [1]
Boiling point210-220 [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1]
SolubilityInsoluble in cold water [1]
Predicted LogP3.6 [1]
Structural Identifiers
[]
Molecular formulaC18H27NO3
IUPAC name(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
SMILESCC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC
InChIInChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6+
InChIKeyYKPUWZUDDOIDPM-SOFGYWHQSA-N
CAS number404-86-4
UNIIS07O44R1ZM
PubChem CID1548943
Toxicity
[]
Mouse:
- oral: 47200 μg/kg
- ip: 6500 μg/kg
- Oral: 47200 μg/kg
Rat:
- ip: 9500 μg/kg
 [1]

Capsaicin (also known as Zostrix, Capsaicine, trans-Capsaicin, Qutenza, Styptysat, Axsain, Ausanil, Isodecenoic acid vanillylamide, Mioton or trans-8-Methyl-N-vanillyl-6-nonenamide) is a substance of the benzylamine class.

Chemistry

 []

Capsaicin is achiral.

Capsaicin matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Capsaicin has been shown to reduce the amount of substance P associated with inflammation - however this is not believed to be its main mechanism in the relief of pain. Capsaicin's mechanism of action is attributed to "defunctionalization" of nociceptor fibers by inducing a topical hypersensitivity reaction on the skin. This alteration in pain mechanisms is due to many of the following: temporary loss of membrane potential, inability to transport neurotrophic factors leading to altered phenotype, and reversible retraction of epidermal and dermal nerve fiber terminals. [1]

Medical side effects []

62 side effects listed on drug labels in (capsaicin).

  • Application site erythema
  • Application site pain
  • Application site burn
  • Instillation site pain
  • Application site pruritus
  • Application site vesicles
  • Application site papules
  • Application site oedema
  • Nasopharyngitis
  • Nausea
  • Sinusitis
  • Vomiting
  • Application site dryness
  • Application site swelling
  • Bronchitis
  • Hypertension
  • Cough
  • Dysgeusia
  • Herpes zoster
  • Hypoaesthesia
  • Pain in extremity
  • Palpitations
  • Pruritus
  • Muscle spasms
  • Tachycardia
  • Burning sensation
  • Oedema peripheral
  • Application site reaction
  • Eye irritation
  • Blood pressure increased
  • Application site irritation
  • Application site rash
  • Throat irritation
  • Application site haematoma
  • Application site paraesthesia
  • Application site inflammation
  • Application site hyperaesthesia
  • Application site urticaria
  • Infection
  • Connective tissue disorder
  • Dizziness
  • Eye disorder
  • Gastrointestinal disorder
  • Headache
  • Cardiac disorder
  • Hyperaesthesia
  • Mediastinal disorder
  • Nervous system disorder
  • Erythema
  • Angiopathy
  • HIV associated nephropathy
  • Peripheral sensory neuropathy
  • Eye pain
  • Skin disorder
  • Skin odour abnormal
  • Application site anaesthesia
  • Burns second degree
  • Neuropathy peripheral
  • Infestation
  • Application site warmth
  • Application site erosion
  • Application site exfoliation

Indications

  • Diabetic
  • Neuralgia
  • Pain
  • Post herpetic neuralgia

Experience reports

Erowid

There are currently 4 experience reports involving capsaicin on : []

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 1548943, Capsaicin. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/1548943
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Capsaicin. UNII: S07O44R1ZM. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/S07O44R1ZM

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 06:50:09
drugspromissing (no DrugsPRO reagent data)2026-11-20 06:50:05
erowidok2026-11-20 06:50:09
gsrsok2026-11-20 06:50:05
hmdbmissing (hmdb.ca refused automated access to HMDB0002227)2026-11-20 06:50:05
keggok2026-11-20 06:50:06
pubchemok2026-11-20 06:50:04
redditmissing (no r/tripreports posts mention it)2026-11-20 06:50:05
siderok2026-11-20 06:50:05
structureok2026-11-20 06:50:05
wikipediamissing (no Wikipedia article with a drug infobox)2026-11-20 06:50:05